drugset / Trial / NCT07299253
Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06
NaSingle-groupOpen-labelOther
Summary
This study aims to systematically evaluate the safety, biodistribution, dosimetry, and preliminary therapeutic potential of \[177Lu\]Lu-TEFAPI-06 through an exploratory first-in-human (FIH) trial.
Timeline
- Start
- 2023-08-16
- Primary completion
- 2024-08-16
- Completion
- 2025-08-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | radionuclide therapy with [177Lu]Lu--TEFAPI-06 | Other / unclassified | — | — |